By Christine O’Brien on 12/22/2009
Pfizer continues their track record of paying big bucks for underhanded dealings. I’m sure it doesn’t matter how much they rack up in damages—as long as they’re allowed to take consumers for everything they’ve got, this just isn’t going to stop.
It hasn’t been too good a year for Pfizer—in the spring, they paid up in a multimillion-dollar lawsuit after shady drug testing in Nigeria . And this fall, they agreed to pay $2.3 billion to settle criminal charges after spending years illegally promoting drugs for off-label uses.
And now they’re ending the year on a low, no…shameful note—paying out $103 million in punitive damages to two women who developed breast cancer after taking hormone drugs made by Wyeth and Pharmacia & Upjohn (now Pfizer subsidiaries).
Of course, it’s all just a drop in the bucket when you’re pulling in almost $48 billion a year in revenue.
With Pfizer raking in that kind of cash, they probably think they can just pay off the people whose lives they destroy, and all will be forgotten. Of course, every time, they insist they’ve “acted responsibly” and that they always have our best interests in mind. As if this is all just a big misunderstanding.